Health CanadaGeneral Alert
Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures)
Published: September 22, 2016Recall ID: 55727Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures)
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 55727 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/zarontin-ethosuximide-defective-capsules-associated-reduced-efficacy-increased |
| Issue | Product safety |
| Title | Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures) |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2016-09-22 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures) Check if your household is affected: https://therecallfile.com/recalls/zarontin-ethosuximide-defective-capsules-associated-with-reduced-effic/CANADA-55727
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordZarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures)